SNAREVAX Trademark
Trademark Overview
On Wednesday, December 20, 2023, a trademark application was filed for SNAREVAX with the United States Patent and Trademark Office. The USPTO has given the SNAREVAX trademark a serial number of 79389053. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, October 31, 2024. This trademark is owned by KAO KABUSHIKI KAISHA (also trading as Kao Corporation). The SNAREVAX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceuticals, namely, vaccines, antiallergic agents, and oligonucleic acid preparations for medical purpose
providing medical and laboratory research in the field of pharmaceuticals; providing information about medical and laboratory research in the field of pharmaceuticals; medical and laboratory research in the field of drug discovery technologies; providing information about medical and laboratory research in the field of drug discovery technologies
General Information
Serial Number | 79389053 |
Word Mark | SNAREVAX |
Filing Date | Wednesday, December 20, 2023 |
Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
Status Date | Thursday, October 31, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Pharmaceuticals, namely, vaccines, antiallergic agents, and oligonucleic acid preparations for medical purpose |
Goods and Services | providing medical and laboratory research in the field of pharmaceuticals; providing information about medical and laboratory research in the field of pharmaceuticals; medical and laboratory research in the field of drug discovery technologies; providing information about medical and laboratory research in the field of drug discovery technologies |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, February 13, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, February 13, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | KAO KABUSHIKI KAISHA (also trading as Kao Corporation) |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | JP |
Trademark Events
Event Date | Event Description |
Friday, February 9, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Tuesday, February 13, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Saturday, February 17, 2024 | APPLICATION FILING RECEIPT MAILED |
Wednesday, April 3, 2024 | ASSIGNED TO EXAMINER |
Monday, April 8, 2024 | NON-FINAL ACTION WRITTEN |
Tuesday, April 9, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Saturday, April 27, 2024 | REFUSAL PROCESSED BY MPU |
Saturday, April 27, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Thursday, May 23, 2024 | REFUSAL PROCESSED BY IB |
Thursday, October 24, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, October 24, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, October 24, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, October 28, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |